President Trump’s preferred coronavirus treatment is the focus of a new study suggesting it could cause more harm than good, but not everybody agrees. We discuss the fallout as trials around the world are paused and countries diverge over policy advice.
12:12 Are we rushing science?
Coronavirus papers are being published extremely quickly, while normally healthy scientific debate is being blown up in the world’s press. Is there a balancing act between timely research and accurate messaging?
18:49 One good thing
Our hosts pick out things that have made them smile in the last week, including hedgerow brews and a trip into the past using AI.
Recipe: Elderflower ‘Champagne’
Video: Denis Shiryaev restores historic footage with AI
22:30 The latest coronavirus research papers
Noah Baker takes a look through some of the key coronavirus papers of the last few weeks.
News: Coronavirus research updates
medRxiv: Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel
Harvard Library: Reductions in commuting mobility predict geographic differences in SARS-CoV-2 prevalence in New York City
Science: DNA vaccine protection against SARS-CoV-2 in rhesus macaques
First up this week, Staff Writer Jennifer Couzin-Frankel talks with host Sarah Crespi about a rare inflammatory response in children that has appeared in a number of COVID-19 hot spots. 
A selection of three essential articles read aloud from the latest issue of The Economist. This week, the chance to flatten the 
